Unicycive Therapeutics, Inc. UNCY
4.70
(0.11)
(2.29%)
as of 25 Sep
- Market cap
- $134.0M
- P/E
- 0.0×
Follow UNCY
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | 0.00 | 0.00 | — | — | — | — | — |
P/S ratio |
— | — | 0.00 | 0.00 | — | — | — | — | — |
P/FCF ratio |
— | — | 0.00 | 0.00 | — | — | — | — | — |
P/Operating CF |
— | — | (4.90) | (1.24) | — | — | — | — | — |
P/B ratio |
— | — | 0.00 | 0.00 | — | — | — | — | — |
Price to Tangible BV |
— | — | 0.00 | 0.00 | — | — | — | — | — |
EV/Sales |
— | — | 0.00 | 0.00 | — | — | — | — | — |
EV/EBITDA |
— | — | 0.00 | 0.00 | — | — | — | — | — |
EV/Operating CF |
— | — | (0.68) | (0.46) | — | — | — | — | — |
EV/FCF |
— | — | (0.68) | (0.46) | — | — | — | — | — |
Quick Ratio |
2.18 | 1.08 | 0.55 | 0.14 | 7.88 | 0.00 | 0.02 | 0.02 | — |
Current Ratio |
2.59 | 1.28 | 0.76 | 0.81 | 8.75 | 0.07 | 0.02 | 0.02 | — |
Net Debt/EBITDA |
1.43 | 0.83 | 0.47 | 0.02 | 1.94 | (0.54) | (0.24) | (1.07) | — |
Debt/Assets |
0.00% | 0.00% | 0.00% | 5.50% | 0.81% | 483.33% | 2,421.05% | 3,610.34% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | (0.33) | 0.01 | (0.37) | (0.52) | (0.87) | — |
Asset Turnover |
0.00 | 0.00 | 0.08 | 0.09 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
1.18 | 0.76 | 0.58 | 0.87 | 0.58 | 0.64 | 0.54 | 0.69 | — |
Capex/Depreciation |
(0.04) | (0.17) | (0.04) | (0.01) | (0.06) | 0.00 | 0.00 | — | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| (141.14%) | (2,088.57%) | 1,469.52% | (225.47%) | (145.04%) | 127.37% | 207.18% | 0.00% | — | |
| (65.73%) | (164.96%) | (369.35%) | (167.50%) | (105.73%) | (2,030.49%) | (9,020.83%) | (7,724.14%) | — | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | (10,018.97%) | 0.00% | 0.00% | 0.00% | — |
Return on Tangible Assets |
(88.25%) | (547.94%) | 764.44% | 2,922.01% | (61.33%) | 84.76% | 244.91% | 92.87% | — |
Average Days of Receivables |
— | — | 0.00 | 0.00 | — | — | — | — | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 1,911.41% | 1,307.68% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 1,266.22% | 690.54% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 261.78% | 110.09% | 0.00% | 0.00% | 0.00% | — | — |
Graham Net Nets |
— | — | (0.21) | (0.08) | — | — | — | — | — |
Graham Number |
— | — | 23.27 | 9.14 | — | — | — | — | — |
Earnings Yield |
— | — | (174.94%) | (240.00%) | — | — | — | — | — |
Free Cash Flow Yield |
— | — | (84.15%) | (207.92%) | — | — | — | — | — |
Revenue per Share |
0.00 | 0.00 | 0.28 | 0.63 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF per Share |
(1.97) | (4.27) | (7.45) | (10.39) | (4.94) | (1.72) | (1.45) | (0.05) | — |
Capex per Share |
0.00 | (0.01) | 0.00 | 0.00 | (0.02) | 0.00 | 0.00 | 0.00 | — |
Free Cash Flow per Share |
(1.97) | (4.28) | (7.46) | (10.40) | (4.96) | (1.72) | (1.45) | (0.05) | — |
Cash per Share |
2.60 | 3.90 | 3.95 | 0.30 | 14.20 | 0.00 | 0.02 | 0.00 | — |
Shareholders Equity per Share |
1.90 | 1.11 | (1.55) | (0.31) | 14.12 | (3.14) | (1.09) | (0.08) | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
1.90 | 1.11 | (1.55) | (0.31) | 14.12 | (3.14) | (1.09) | (0.08) | — |
Free Cash Flow |
(31.34) | (28.65) | (18.29) | (15.65) | (5.80) | (1.46) | (1.18) | (0.77) | — |
Working Capital |
30.02 | 6.83 | (4.13) | (0.64) | 16.31 | (2.67) | (0.88) | (1.21) | — |
Capital Expenditures |
(0.02) | (0.07) | (0.01) | 0.00 | (0.03) | — | — | — | — |
Net Current Asset Value |
30.02 | 6.71 | (4.60) | (0.64) | 16.15 | (2.67) | (0.88) | (1.21) | — |
EV/EBIT |
— | — | 0.00 | 0.00 | — | — | — | — | — |
Capex to Sales |
0.00 | 0.00 | 0.02 | 0.00 | 0.00 | — | — | — | — |
Net Profit Margin |
0.00% | 0.00% | (4,653.48%) | (1,898.84%) | 0.00% | 0.00% | 0.00% | 0.00% | — |
Price to Operating Income |
— | — | 0.00 | 0.00 | — | — | — | — | — |
| Other line items | |||||||||
Depreciation/Fixed assets |
8.67 | 5.71 | 10.92 | 7.32 | 17.89 | 0.00 | 0.00 | — | — |
Cash ROIC |
(43.91%) | (85.34%) | (310.74%) | (10,884.03%) | (17.45%) | 86.59% | 287.53% | 578.36% | — |
Accounts Receivable Turnover |
— | — | 0.00 | 0.00 | — | — | — | — | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | — | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | — | — | — | — |
Average Payables |
0.72 | 0.95 | 0.87 | 0.82 | 0.46 | 0.25 | 0.19 | — | — |
Average Assets |
40.40 | 22.93 | 8.50 | 10.78 | 9.47 | 0.11 | 0.02 | 0.01 | — |
Average Common Equity |
18.81 | 1.81 | (2.14) | 8.01 | 6.91 | (1.78) | (1.04) | — | — |
Columns are period end dates